Combivent Respimat

Boehringer Ingelheim Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: May 23, 2023
Approval ID: 9832312e-0310-4ab6-8501-afa976fc7eb2
Products: 1 registered
Version: 16

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use COMBIVENT RESPIMAT safely and effectively. See full prescribing information for COMBIVENT RESPIMAT. COMBIVENT RESPIMAT (ipratropium bromide and albuterol inhalation spray), for oral inhalation useInitial U.S. Approval: 1996

Quick Stats

Total Products1

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.